Literature DB >> 12394814

Varicella-related hospitalizations in the vaccine era.

Adam J Ratner1.   

Abstract

BACKGROUND AND AIM: Varicella is normally a self-limited disease of childhood that does not require hospitalization. In the prevaccine era varicella caused >9000 hospitalizations per year. To determine whether the varicella vaccine, licensed in 1995, has decreased hospitalizations because of varicella, we examined national rates of varicella-related hospital discharges (VRHD) covering a 12-year period that included pre- and postvaccine data.
METHODS: Data from the 1988 to 1999 National Hospital Discharge Survey and population estimates from the National Center for Health Statistics were used to calculate biennial rates of VRHD. To control for coding consistency, rates of invasive disease caused by were calculated for the same time period.
RESULTS: The rate of VRHD for 1998 to 1999 (4.42 hospitalizations per 100 000 person-years) was the lowest of any of the periods measured, but this difference was not statistically significant. The same was true of VRHD limited to cases with varicella coded as the primary diagnosis. A trend toward a decrease in VRHD was observed in all age groups examined, although none was statistically significant. Calculated rates from this national data set were in agreement with prior studies using active surveillance, and the previously documented fall in hospitalizations caused by invasive disease was demonstrated using these methods.
CONCLUSIONS: Although it is uncommon for children with varicella to require hospitalization, these cases are an important contributor to cost and morbidity of varicella. In contrast to predictions of prelicensure mathematical models, there has not been a significant decrease in total or first diagnosis VRHD since the vaccine became available. Current coverage levels are below those used in prelicensure models. Increased acceptance of the varicella vaccine by parents and practitioners may aid in the further decrease of varicella-related hospitalizations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12394814     DOI: 10.1097/00006454-200210000-00008

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  9 in total

1.  Varicella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccination era.

Authors:  Adriana S Lopez; John Zhang; Cedric Brown; Stephanie Bialek
Journal:  Pediatrics       Date:  2011-01-03       Impact factor: 7.124

2.  Control of varicella disease, version 2.0.

Authors:  David W Kimberlin
Journal:  J Infect Dis       Date:  2011-02-01       Impact factor: 5.226

Review 3.  Should the UK introduce varicella vaccine?

Authors:  Marion Roderick; Athimalaipet V Ramanan; Adam Finn
Journal:  Arch Dis Child       Date:  2007-11-08       Impact factor: 3.791

4.  Decline in varicella-related ambulatory visits and hospitalizations in the United States since routine immunization against varicella.

Authors:  Samir S Shah; Sarah M Wood; Xiquan Luan; Adam J Ratner
Journal:  Pediatr Infect Dis J       Date:  2010-03       Impact factor: 2.129

5.  Intravenous immunoglobulin in children with streptococcal toxic shock syndrome.

Authors:  Samir S Shah; Matthew Hall; Raj Srivastava; Anupama Subramony; James E Levin
Journal:  Clin Infect Dis       Date:  2009-11-01       Impact factor: 9.079

6.  The burden of varicella in Germany. Potential risks and economic impact.

Authors:  Kurt Banz; Stefan Wagenpfeil; Albrecht Neiss; Thomas Hammerschmidt; Peter Wutzler
Journal:  Eur J Health Econ       Date:  2004-02

Review 7.  Impact of varicella vaccine on varicella-zoster virus dynamics.

Authors:  D Scott Schmid; Aisha O Jumaan
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

Review 8.  The impact of varicella vaccination on varicella-related hospitalization rates: global data review.

Authors:  Maki Hirose; Alfredo Elias Gilio; Angela Esposito Ferronato; Selma Lopes Betta Ragazzi
Journal:  Rev Paul Pediatr       Date:  2016-02-17

9.  Impact of the tetra viral vaccine introduction on varicella morbidity and mortality in the Brazilian macro regions.

Authors:  Marcella Z Ribeiro; Emil Kupek; Paulo V Z Ribeiro; Carlos Eduardo Andrade Pinheiro
Journal:  J Pediatr (Rio J)       Date:  2019-12-18       Impact factor: 2.990

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.